On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...